Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more episode artwork

EPISODE · Jul 20, 2021 · 12 MIN

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

from JAMA Editors' Summary

Editors' Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the July 20, 2021 issue.

Episode metadata supplied by the publisher feed · Published Jul 20, 2021

Embed this episode

Ready to play

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

0:00 12:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 12 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on July 20, 2021.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!